Table of Content

1 Brand Drugs Market Overview
1.1 Brand Drugs Product Overview
1.2 Brand Drugs Market Segment by Type
1.2.1 Biopharmaceutical
1.2.2 Chemistry Medicine
1.3 Global Brand Drugs Market Size by Type
1.3.1 Global Brand Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Brand Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Brand Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Brand Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Brand Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Brand Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Brand Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Brand Drugs Sales Breakdown by Type (2018-2024)
2 Global Brand Drugs Market Competition by Company
2.1 Global Top Players by Brand Drugs Sales (2018-2024)
2.2 Global Top Players by Brand Drugs Revenue (2018-2024)
2.3 Global Top Players by Brand Drugs Price (2018-2024)
2.4 Global Top Manufacturers Brand Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Brand Drugs Market Competitive Situation and Trends
2.5.1 Brand Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Brand Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Brand Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Brand Drugs Market
2.8 Key Manufacturers Brand Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Brand Drugs Status and Outlook by Region
3.1 Global Brand Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Brand Drugs Historic Market Size by Region
3.2.1 Global Brand Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Brand Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Brand Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Brand Drugs Forecasted Market Size by Region
3.3.1 Global Brand Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Brand Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Brand Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Brand Drugs by Application
4.1 Brand Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Brand Drugs Market Size by Application
4.2.1 Global Brand Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Brand Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Brand Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Brand Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Brand Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Brand Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Brand Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Brand Drugs Sales Breakdown by Application (2018-2024)
5 North America Brand Drugs by Country
5.1 North America Brand Drugs Historic Market Size by Country
5.1.1 North America Brand Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Brand Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Brand Drugs Sales in Value by Country (2018-2024)
5.2 North America Brand Drugs Forecasted Market Size by Country
5.2.1 North America Brand Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Brand Drugs Sales in Value by Country (2024-2034)
6 Europe Brand Drugs by Country
6.1 Europe Brand Drugs Historic Market Size by Country
6.1.1 Europe Brand Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Brand Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Brand Drugs Sales in Value by Country (2018-2024)
6.2 Europe Brand Drugs Forecasted Market Size by Country
6.2.1 Europe Brand Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Brand Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Brand Drugs by Region
7.1 Asia-Pacific Brand Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Brand Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Brand Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Brand Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Brand Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Brand Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Brand Drugs Sales in Value by Region (2024-2034)
8 Latin America Brand Drugs by Country
8.1 Latin America Brand Drugs Historic Market Size by Country
8.1.1 Latin America Brand Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Brand Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Brand Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Brand Drugs Forecasted Market Size by Country
8.2.1 Latin America Brand Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Brand Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Brand Drugs by Country
9.1 Middle East and Africa Brand Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Brand Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Brand Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Brand Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Brand Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Brand Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Brand Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Brand Drugs Products Offered
10.1.5 Pfizer Recent Development
10.2 Roche
10.2.1 Roche Company Information
10.2.2 Roche Introduction and Business Overview
10.2.3 Roche Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Roche Brand Drugs Products Offered
10.2.5 Roche Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sanofi Brand Drugs Products Offered
10.3.5 Sanofi Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information
10.4.2 Johnson & Johnson Introduction and Business Overview
10.4.3 Johnson & Johnson Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Johnson & Johnson Brand Drugs Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 Merck & Co. (MSD)
10.5.1 Merck & Co. (MSD) Company Information
10.5.2 Merck & Co. (MSD) Introduction and Business Overview
10.5.3 Merck & Co. (MSD) Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Merck & Co. (MSD) Brand Drugs Products Offered
10.5.5 Merck & Co. (MSD) Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Novartis Brand Drugs Products Offered
10.6.5 Novartis Recent Development
10.7 AbbVie
10.7.1 AbbVie Company Information
10.7.2 AbbVie Introduction and Business Overview
10.7.3 AbbVie Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 AbbVie Brand Drugs Products Offered
10.7.5 AbbVie Recent Development
10.8 Gilead Sciences
10.8.1 Gilead Sciences Company Information
10.8.2 Gilead Sciences Introduction and Business Overview
10.8.3 Gilead Sciences Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Gilead Sciences Brand Drugs Products Offered
10.8.5 Gilead Sciences Recent Development
10.9 GlaxoSmithKline (GSK)
10.9.1 GlaxoSmithKline (GSK) Company Information
10.9.2 GlaxoSmithKline (GSK) Introduction and Business Overview
10.9.3 GlaxoSmithKline (GSK) Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 GlaxoSmithKline (GSK) Brand Drugs Products Offered
10.9.5 GlaxoSmithKline (GSK) Recent Development
10.10 Amgen
10.10.1 Amgen Company Information
10.10.2 Amgen Introduction and Business Overview
10.10.3 Amgen Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Amgen Brand Drugs Products Offered
10.10.5 Amgen Recent Development
10.11 AstraZeneca
10.11.1 AstraZeneca Company Information
10.11.2 AstraZeneca Introduction and Business Overview
10.11.3 AstraZeneca Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 AstraZeneca Brand Drugs Products Offered
10.11.5 AstraZeneca Recent Development
10.12 Bristol-Myers Squibb
10.12.1 Bristol-Myers Squibb Company Information
10.12.2 Bristol-Myers Squibb Introduction and Business Overview
10.12.3 Bristol-Myers Squibb Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Bristol-Myers Squibb Brand Drugs Products Offered
10.12.5 Bristol-Myers Squibb Recent Development
10.13 Eli Lilly
10.13.1 Eli Lilly Company Information
10.13.2 Eli Lilly Introduction and Business Overview
10.13.3 Eli Lilly Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Eli Lilly Brand Drugs Products Offered
10.13.5 Eli Lilly Recent Development
10.14 Teva
10.14.1 Teva Company Information
10.14.2 Teva Introduction and Business Overview
10.14.3 Teva Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Teva Brand Drugs Products Offered
10.14.5 Teva Recent Development
10.15 Bayer
10.15.1 Bayer Company Information
10.15.2 Bayer Introduction and Business Overview
10.15.3 Bayer Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Bayer Brand Drugs Products Offered
10.15.5 Bayer Recent Development
10.16 Novo Nordisk
10.16.1 Novo Nordisk Company Information
10.16.2 Novo Nordisk Introduction and Business Overview
10.16.3 Novo Nordisk Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Novo Nordisk Brand Drugs Products Offered
10.16.5 Novo Nordisk Recent Development
10.17 Allergan
10.17.1 Allergan Company Information
10.17.2 Allergan Introduction and Business Overview
10.17.3 Allergan Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Allergan Brand Drugs Products Offered
10.17.5 Allergan Recent Development
10.18 Takeda
10.18.1 Takeda Company Information
10.18.2 Takeda Introduction and Business Overview
10.18.3 Takeda Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Takeda Brand Drugs Products Offered
10.18.5 Takeda Recent Development
10.19 Boehringer Ingelheim
10.19.1 Boehringer Ingelheim Company Information
10.19.2 Boehringer Ingelheim Introduction and Business Overview
10.19.3 Boehringer Ingelheim Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Boehringer Ingelheim Brand Drugs Products Offered
10.19.5 Boehringer Ingelheim Recent Development
10.20 Takeda
10.20.1 Takeda Company Information
10.20.2 Takeda Introduction and Business Overview
10.20.3 Takeda Brand Drugs Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Takeda Brand Drugs Products Offered
10.20.5 Takeda Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Brand Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Brand Drugs Industrial Chain Analysis
11.4 Brand Drugs Market Dynamics
11.4.1 Brand Drugs Industry Trends
11.4.2 Brand Drugs Market Drivers
11.4.3 Brand Drugs Market Challenges
11.4.4 Brand Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Brand Drugs Distributors
12.3 Brand Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Biopharmaceutical
Table 2. Major Company of Chemistry Medicine
Table 3. Global Brand Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Brand Drugs Sales by Type (2018-2024) & (K Units)
Table 5. Global Brand Drugs Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Brand Drugs Sales by Type (2018-2024) & (US& Million)
Table 7. Global Brand Drugs Market Share in Value by Type (2018-2024)
Table 8. Global Brand Drugs Price by Type (2018-2024) & (USD/Unit)
Table 9. Global Brand Drugs Sales by Type (2024-2034) & (K Units)
Table 10. Global Brand Drugs Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Brand Drugs Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Brand Drugs Sales Market Share in Value by Type (2024-2034)
Table 13. Global Brand Drugs Price by Type (2024-2034) & (USD/Unit)
Table 14. North America Brand Drugs Sales by Type (2018-2024) & (K Units)
Table 15. North America Brand Drugs Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Brand Drugs Sales (K Units) by Type (2018-2024)
Table 17. Europe Brand Drugs Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Brand Drugs Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Brand Drugs Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Brand Drugs Sales (K Units) by Type (2018-2024)
Table 21. Latin America Brand Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Brand Drugs Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Brand Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Brand Drugs Sales by Company (2018-2024) & (K Units)
Table 25. Global Brand Drugs Sales Share by Company (2018-2024)
Table 26. Global Brand Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Brand Drugs Revenue Share by Company (2018-2024)
Table 28. Global Market Brand Drugs Price by Company (2018-2024) & (USD/Unit)
Table 29. Global Brand Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Brand Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Brand Drugs as of 2022)
Table 32. Date of Key Manufacturers Enter into Brand Drugs Market
Table 33. Key Manufacturers Brand Drugs Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Brand Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Brand Drugs Sales by Region (2018-2024) & (K Units)
Table 37. Global Brand Drugs Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Brand Drugs Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Brand Drugs Sales Market Share in Value by Region (2018-2024)
Table 40. Global Brand Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global Brand Drugs Sales by Region (2024-2034) & (K Units)
Table 42. Global Brand Drugs Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Brand Drugs Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Brand Drugs Sales Market Share in Value by Region (2024-2034)
Table 45. Global Brand Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 46. Global Brand Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Brand Drugs Sales by Application (2018-2024) & (K Units)
Table 48. Global Brand Drugs Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Brand Drugs Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Brand Drugs Sales Market Share in Value by Application (2018-2024)
Table 51. Global Brand Drugs Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Brand Drugs Sales by Application (2024-2034) & (K Units)
Table 53. Global Brand Drugs Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Brand Drugs Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Brand Drugs Sales Market Share in Value by Application (2024-2034)
Table 56. Global Brand Drugs Price by Application (2024-2034) & (USD/Unit)
Table 57. North America Brand Drugs Sales by Application (2018-2024) (K Units)
Table 58. North America Brand Drugs Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Brand Drugs Sales by Application (2018-2024) (K Units)
Table 60. Europe Brand Drugs Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Brand Drugs Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Brand Drugs Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Brand Drugs Sales by Application (2018-2024) (K Units)
Table 64. Latin America Brand Drugs Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Brand Drugs Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Brand Drugs Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Brand Drugs Sales by Country (2018-2024) & (K Units)
Table 68. North America Brand Drugs Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Brand Drugs Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Brand Drugs Sales Market Share in Value by Country (2018-2024)
Table 71. North America Brand Drugs Sales by Country (2024-2034) & (K Units)
Table 72. North America Brand Drugs Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Brand Drugs Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Brand Drugs Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Brand Drugs Sales by Country (2018-2024) & (K Units)
Table 76. Europe Brand Drugs Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Brand Drugs Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Brand Drugs Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Brand Drugs Sales by Country (2024-2034) & (K Units)
Table 80. Europe Brand Drugs Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Brand Drugs Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Brand Drugs Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Brand Drugs Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Brand Drugs Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Brand Drugs Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Brand Drugs Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Brand Drugs Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Brand Drugs Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Brand Drugs Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Brand Drugs Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Brand Drugs Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Brand Drugs Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Brand Drugs Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Brand Drugs Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Brand Drugs Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Brand Drugs Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Brand Drugs Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Brand Drugs Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Brand Drugs Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Brand Drugs Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Brand Drugs Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Brand Drugs Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Brand Drugs Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Brand Drugs Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Brand Drugs Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Brand Drugs Sales Market Share in Value by Country (2024-2034)
Table 107. Pfizer Company Information
Table 108. Pfizer Introduction and Business Overview
Table 109. Pfizer Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Pfizer Brand Drugs Product
Table 111. Pfizer Recent Development
Table 112. Roche Company Information
Table 113. Roche Introduction and Business Overview
Table 114. Roche Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Roche Brand Drugs Product
Table 116. Roche Recent Development
Table 117. Sanofi Company Information
Table 118. Sanofi Introduction and Business Overview
Table 119. Sanofi Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Sanofi Brand Drugs Product
Table 121. Sanofi Recent Development
Table 122. Johnson & Johnson Company Information
Table 123. Johnson & Johnson Introduction and Business Overview
Table 124. Johnson & Johnson Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Johnson & Johnson Brand Drugs Product
Table 126. Johnson & Johnson Recent Development
Table 127. Merck & Co. (MSD) Company Information
Table 128. Merck & Co. (MSD) Introduction and Business Overview
Table 129. Merck & Co. (MSD) Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Merck & Co. (MSD) Brand Drugs Product
Table 131. Merck & Co. (MSD) Recent Development
Table 132. Novartis Company Information
Table 133. Novartis Introduction and Business Overview
Table 134. Novartis Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Novartis Brand Drugs Product
Table 136. Novartis Recent Development
Table 137. AbbVie Company Information
Table 138. AbbVie Introduction and Business Overview
Table 139. AbbVie Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. AbbVie Brand Drugs Product
Table 141. AbbVie Recent Development
Table 142. Gilead Sciences Company Information
Table 143. Gilead Sciences Introduction and Business Overview
Table 144. Gilead Sciences Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Gilead Sciences Brand Drugs Product
Table 146. Gilead Sciences Recent Development
Table 147. GlaxoSmithKline (GSK) Company Information
Table 148. GlaxoSmithKline (GSK) Introduction and Business Overview
Table 149. GlaxoSmithKline (GSK) Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. GlaxoSmithKline (GSK) Brand Drugs Product
Table 151. GlaxoSmithKline (GSK) Recent Development
Table 152. Amgen Company Information
Table 153. Amgen Introduction and Business Overview
Table 154. Amgen Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. Amgen Brand Drugs Product
Table 156. Amgen Recent Development
Table 157. AstraZeneca Company Information
Table 158. AstraZeneca Introduction and Business Overview
Table 159. AstraZeneca Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 160. AstraZeneca Brand Drugs Product
Table 161. AstraZeneca Recent Development
Table 162. Bristol-Myers Squibb Company Information
Table 163. Bristol-Myers Squibb Introduction and Business Overview
Table 164. Bristol-Myers Squibb Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 165. Bristol-Myers Squibb Brand Drugs Product
Table 166. Bristol-Myers Squibb Recent Development
Table 167. Eli Lilly Company Information
Table 168. Eli Lilly Introduction and Business Overview
Table 169. Eli Lilly Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 170. Eli Lilly Brand Drugs Product
Table 171. Eli Lilly Recent Development
Table 172. Teva Company Information
Table 173. Teva Introduction and Business Overview
Table 174. Teva Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 175. Teva Brand Drugs Product
Table 176. Teva Recent Development
Table 177. Bayer Company Information
Table 178. Bayer Introduction and Business Overview
Table 179. Bayer Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 180. Bayer Brand Drugs Product
Table 181. Bayer Recent Development
Table 182. Novo Nordisk Company Information
Table 183. Novo Nordisk Introduction and Business Overview
Table 184. Novo Nordisk Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 185. Novo Nordisk Brand Drugs Product
Table 186. Novo Nordisk Recent Development
Table 187. Allergan Company Information
Table 188. Allergan Introduction and Business Overview
Table 189. Allergan Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 190. Allergan Brand Drugs Product
Table 191. Allergan Recent Development
Table 192. Takeda Company Information
Table 193. Takeda Introduction and Business Overview
Table 194. Takeda Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 195. Takeda Brand Drugs Product
Table 196. Takeda Recent Development
Table 197. Boehringer Ingelheim Company Information
Table 198. Boehringer Ingelheim Introduction and Business Overview
Table 199. Boehringer Ingelheim Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 200. Boehringer Ingelheim Brand Drugs Product
Table 201. Boehringer Ingelheim Recent Development
Table 202. Takeda Company Information
Table 203. Takeda Introduction and Business Overview
Table 204. Takeda Brand Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 205. Takeda Brand Drugs Product
Table 206. Takeda Recent Development
Table 207. Key Raw Materials Lists
Table 208. Raw Materials Key Suppliers Lists
Table 209. Brand Drugs Market Trends
Table 210. Brand Drugs Market Drivers
Table 211. Brand Drugs Market Challenges
Table 212. Brand Drugs Market Restraints
Table 213. Brand Drugs Distributors List
Table 214. Brand Drugs Downstream Customers
Table 215. Research Programs/Design for This Report
Table 216. Key Data Information from Secondary Sources
Table 217. Key Data Information from Primary Sources
List of Figures
Figure 1. Brand Drugs Product Picture
Figure 2. Global Brand Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Brand Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Brand Drugs Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Biopharmaceutical
Figure 6. Global Biopharmaceutical Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Chemistry Medicine
Figure 8. Global Chemistry Medicine Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Global Brand Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Brand Drugs Sales Market Share by Type in 2022 & 2034
Figure 11. North America Brand Drugs Sales Market Share in Volume by Type in 2022
Figure 12. North America Brand Drugs Sales Market Share in Value by Type in 2022
Figure 13. Europe Brand Drugs Sales Market Share in Volume by Type in 2022
Figure 14. Europe Brand Drugs Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Brand Drugs Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Brand Drugs Sales Market Share in Value by Type in 2022
Figure 17. Latin America Brand Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Brand Drugs Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Brand Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Brand Drugs Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Brand Drugs Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Brand Drugs Revenue in 2022
Figure 23. Brand Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2034) & (K Units)
Figure 26. Product Picture of Clinic
Figure 27. Global Clinic Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Global Brand Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Brand Drugs Sales Market Share by Application in 2022 & 2034
Figure 32. North America Brand Drugs Sales Market Share in Volume by Application in 2022
Figure 33. North America Brand Drugs Sales Market Share in Value by Application in 2022
Figure 34. Europe Brand Drugs Sales Market Share in Volume by Application in 2022
Figure 35. Europe Brand Drugs Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Brand Drugs Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Brand Drugs Sales Market Share in Value by Application in 2022
Figure 38. Latin America Brand Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Brand Drugs Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Brand Drugs Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Brand Drugs Manufacturing Cost Structure
Figure 43. Brand Drugs Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed